Jiu'an Medical: Stock Price Abnormal Fluctuation Indicates Multiple Investment Risks

Jiu'an Medical announced that the company's stock had a deviation value exceeding 20% on July 15 and 16, 2026, for two consecutive trading days, indicating abnormal fluctuations. The company's fundamentals have not changed, and the stock price is affected by market sentiment. The company's investment in science and technology innovation does not guarantee capital preservation or minimum returns, and there is a risk of investment failure and loss. The company expects a net profit of 2.8 billion to 3.4 billion yuan for the first half of 2026, with performance affected by the returns from the science and technology innovation investments. In addition, subsidiary Jiu'an Hong Kong indirectly invested 750 million yuan in Hangzhou Shensou, holding approximately 0.21% of the shares, with risks such as lower-than-expected commercial returns.